全文获取类型
收费全文 | 93308篇 |
免费 | 7473篇 |
国内免费 | 3660篇 |
专业分类
耳鼻咽喉 | 320篇 |
儿科学 | 1640篇 |
妇产科学 | 1102篇 |
基础医学 | 15416篇 |
口腔科学 | 1015篇 |
临床医学 | 8445篇 |
内科学 | 21810篇 |
皮肤病学 | 1402篇 |
神经病学 | 3656篇 |
特种医学 | 1765篇 |
外国民族医学 | 10篇 |
外科学 | 5666篇 |
综合类 | 11956篇 |
现状与发展 | 21篇 |
一般理论 | 47篇 |
预防医学 | 9870篇 |
眼科学 | 852篇 |
药学 | 10188篇 |
43篇 | |
中国医学 | 4068篇 |
肿瘤学 | 5149篇 |
出版年
2024年 | 207篇 |
2023年 | 3106篇 |
2022年 | 6940篇 |
2021年 | 9060篇 |
2020年 | 6646篇 |
2019年 | 2613篇 |
2018年 | 2494篇 |
2017年 | 2421篇 |
2016年 | 2800篇 |
2015年 | 3071篇 |
2014年 | 5002篇 |
2013年 | 5198篇 |
2012年 | 5065篇 |
2011年 | 5439篇 |
2010年 | 4445篇 |
2009年 | 4200篇 |
2008年 | 4142篇 |
2007年 | 4048篇 |
2006年 | 3697篇 |
2005年 | 3136篇 |
2004年 | 2639篇 |
2003年 | 2284篇 |
2002年 | 1826篇 |
2001年 | 1594篇 |
2000年 | 1238篇 |
1999年 | 1081篇 |
1998年 | 980篇 |
1997年 | 813篇 |
1996年 | 702篇 |
1995年 | 693篇 |
1994年 | 583篇 |
1993年 | 492篇 |
1992年 | 463篇 |
1991年 | 372篇 |
1990年 | 338篇 |
1989年 | 298篇 |
1988年 | 249篇 |
1987年 | 212篇 |
1986年 | 174篇 |
1985年 | 478篇 |
1984年 | 496篇 |
1983年 | 392篇 |
1982年 | 401篇 |
1981年 | 337篇 |
1980年 | 307篇 |
1979年 | 273篇 |
1978年 | 210篇 |
1977年 | 169篇 |
1976年 | 180篇 |
1975年 | 163篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
92.
93.
《Transfusion and apheresis science》2020,59(4):102855
The activation of the innate and adaptive immune systems by SARS-CoV-2 causes the release of several inflammatory cytokines, including IL-6. The inflammatory hypercytokinemia causes immunopathological changes in the lungs including vascular leakage, and alveolar edema. As a result of these changes in the lungs, hypoxia and acute respiratory distress syndrome occur in patients with COVID-19. Even though there are clinical trials on the development of therapeutics and vaccines, there are currently no licensed vaccines or therapeutics for COVID-19. Pharmacological approaches have shown poor results in sepsis-like syndromes caused by the hypercytokinemia. Suppressing the cytokine storm is an important way to prevent the organ damage in patients with COVID-19. Extracorporeal blood purification could be proposed as an adjunctive therapy for sepsis, aiming to control the associated dysregulation of the immune system, which is known to protect organ functions. Several extracorporeal blood purification therapies are now available, and most of them target endotoxins and/or the cytokines and aim improving the immune response. For this purpose, plasmapheresis and immunoadsorption may be an important adjunctive treatment option to manage the complications caused by cytokine storm in critically ill patients with COVID-19. 相似文献
94.
95.
《Clinical oncology (Royal College of Radiologists (Great Britain))》2020,32(6):347-353
The current COVID-19 pandemic presents a substantial obstacle to cancer patient care. Data from China as well as risk models suppose that cancer patients, particularly those on active, immunosuppressive therapies are at higher risks of severe infection from the illness. In addition, staff illness and restructuring of services to deal with the crisis will inevitably place treatment capacities under significant strain. These guidelines aim to expand on those provided by NHS England regarding cancer care during the coronavirus pandemic by examining the known literature and provide guidance in managing patients with urothelial and rarer urinary tract cancers. In particular, they address the estimated risk and benefits of standard treatments and consider the alternatives in the current situation. As a result, it is recommended that this guidance will help form a framework for shared decision making with patients. Moreover, they do not advise a one-size-fits-all approach but recommend continual assessment of the situation with discussion within and between centres. 相似文献
96.
J. Alarcón-Rodríguez M. Fernández-Velilla A. Ureña-Vacas J.J. Martín-Pinacho J.A. Rigual-Bobillo A. Jaureguízar-Oriol L. Gorospe-Sarasúa 《Radiologia》2021,63(3):258-269
Most of the patients who overcome the SARS-CoV-2 infection do not present complications and do not require a specific follow-up, but a significant proportion (especially those with moderate / severe clinical forms of the disease) require clinicalradiological follow-up. Although there are hardly any references or clinical guidelines regarding the long-term follow-up of post-COVID-19 patients, radiological exams are being performed and monographic surveillance consultations are being set up in most of the hospitals to meet their needs. The purpose of this work is to share our experience in the management of the post-COVID-19 patient in two institutions thathave had a high incidence of COVID-19 and to propose general follow-uprecommendations from a clinical and radiological perspective. 相似文献
97.
98.
99.
100.
《Clinical Lymphoma, Myeloma & Leukemia》2020,20(11):720-723
Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) has a high death rate in patients with comorbidities or in an immunocompromised state. We report a mild and attenuated SARS CoV-2 infection in a patient who is 17 months post stem cell transplantation and maintained on the JAK/STAT inhibitor ruxolitinib, a proposed novel therapy for SARS CoV-2 pneumonia. 相似文献